Skip to main content

Main menu

  • Home
  • Current Issue
  • Ahead of Print
  • Past Issues
  • Info for
    • Authors
    • Print Subscriptions
  • About
    • About the Journal
    • About the Academy
    • Editorial Board
  • Feedback
  • Alerts
  • AAPL

User menu

  • Alerts

Search

  • Advanced search
Journal of the American Academy of Psychiatry and the Law
  • AAPL
  • Alerts
Journal of the American Academy of Psychiatry and the Law

Advanced Search

  • Home
  • Current Issue
  • Ahead of Print
  • Past Issues
  • Info for
    • Authors
    • Print Subscriptions
  • About
    • About the Journal
    • About the Academy
    • Editorial Board
  • Feedback
  • Alerts
Research ArticleRegular Article

The Evolving Medicolegal Precedent for Medications for Opioid Use Disorder in U.S. Jails and Prisons

Takeo Toyoshima, Dale E. McNiel, Ariel Schonfeld and Renée Binder
Journal of the American Academy of Psychiatry and the Law Online August 2021, JAAPL.200127-20; DOI: https://doi.org/10.29158/JAAPL.200127-20
Takeo Toyoshima
Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA. Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA. , San Francisco, CA. Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dale E. McNiel
Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA. Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA. , San Francisco, CA. Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ariel Schonfeld
Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA. Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA. , San Francisco, CA. Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Renée Binder
Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA. Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA. , San Francisco, CA. Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

JAAPL.200127-20
DOI 
https://doi.org/10.29158/JAAPL.200127-20
PubMed 
34341145

Published By 
Journal of the American Academy of Psychiatry and the Law Online
Print ISSN 
1093-6793
History 
  • Published online August 2, 2021.

Article Versions

  • You are currently viewing a Latest version of this article (August 2, 2021 - 12:40).
  • View the most recent version of this article
Copyright & Usage 
© 2021 American Academy of Psychiatry and the Law

Author Information

  1. Takeo Toyoshima, MD,
  2. Dale E. McNiel, PhD,
  3. Ariel Schonfeld, MD and
  4. Renée Binder, MD
  1. Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA. Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA. , San Francisco, CA. Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA.
  1. Address correspondence to: Takeo Toyoshima, MD. E-mail: takeo.toyoshima{at}ucsf.edu.

PreviousNext
Back to top

In this issue

Journal of the American Academy of Psychiatry and the Law Online: 53 (1)
Journal of the American Academy of Psychiatry and the Law Online
Vol. 53, Issue 1
1 Mar 2025
  • Table of Contents
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in recommending The Journal of the American Academy of Psychiatry and the Law site.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Evolving Medicolegal Precedent for Medications for Opioid Use Disorder in U.S. Jails and Prisons
(Your Name) has forwarded a page to you from Journal of the American Academy of Psychiatry and the Law
(Your Name) thought you would like to see this page from the Journal of the American Academy of Psychiatry and the Law web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The Evolving Medicolegal Precedent for Medications for Opioid Use Disorder in U.S. Jails and Prisons
Takeo Toyoshima, Dale E. McNiel, Ariel Schonfeld, Renée Binder
Journal of the American Academy of Psychiatry and the Law Online Aug 2021, JAAPL.200127-20; DOI: 10.29158/JAAPL.200127-20

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
The Evolving Medicolegal Precedent for Medications for Opioid Use Disorder in U.S. Jails and Prisons
Takeo Toyoshima, Dale E. McNiel, Ariel Schonfeld, Renée Binder
Journal of the American Academy of Psychiatry and the Law Online Aug 2021, JAAPL.200127-20; DOI: 10.29158/JAAPL.200127-20
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • The Opioid Epidemic and MOUD
    • OUD in the U.S. Criminal Justice System
    • Barriers to MOUD in Correctional Settings
    • MOUD to Reduce Postincarceration Deaths
    • Legal Precedent for MOUDs in Corrections
    • Overdose Deaths While Incarcerated
    • MOUD to Curb In-Prison Deaths
    • Conclusion and Future Directions
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • A Forensic Science-Based Model for Identifying and Mitigating Forensic Mental Health Expert Biases
  • Bias in Peer Review of Forensic Psychiatry Publications
  • Reconsidering the Relationship Between Criminal Insanity and Delusions
Show more Regular Article

Similar Articles

Keywords

  • opioid use disorder
  • addiction
  • medication assisted treatment
  • jail
  • prison
  • correctional psychiatry

Site Navigation

  • Home
  • Current Issue
  • Ahead of Print
  • Archive
  • Information for Authors
  • About the Journal
  • Editorial Board
  • Feedback
  • Alerts

Other Resources

  • Academy Website
  • AAPL Meetings
  • AAPL Annual Review Course

Reviewers

  • Peer Reviewers

Other Publications

  • AAPL Practice Guidelines
  • AAPL Newsletter
  • AAPL Ethics Guidelines
  • AAPL Amicus Briefs
  • Landmark Cases

Customer Service

  • Cookie Policy
  • Reprints and Permissions
  • Order Physical Copy

Copyright © 2025 by The American Academy of Psychiatry and the Law